Vector BioMed, a leading lentiviral vector supplier and contract vector development and manufacturing organization (CVDMO), today announced the expansion of its LENTIVERSEtm platform alongside the ...

Reports Adjusted Net Income of $754 Million, or Adjusted Diluted EPS of $1.70, for Third Quarter 2025. Revises Full Year 2025 ...

Fifth annual Magnetic North event will focus on supporting newcomers and connecting international students to careers ...

IonQ, Inc. has a truly unique ability to land and expand in quantum computing, quantum networking, quantum sensing, and ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...